IMAP phosphodiesterase assay
IMAP Technology offers a homogeneous, non-antibody-based platform for screening kinases, phosphatases, and phosphodiesterases. Stable and robust, it is amenable to miniaturization and yields high-quality data with excellent Z’ factor values, making it suitable for inhibitor screening. Unlike some other methods, IMAP measures direct binding for more relevant results. IMAP TR-FRET assays also enable direct Km determination.